Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors

ConditionCharcot Foot
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University

About this trial

Diabetes mellitus (DM) is among the most common metabolic disorders globally. According to the data from international research, the number of persons with diabetes mellitus reached 366 million in 2011 and is predicted to increase to 552 million by 2030.

Eligibility criteria

Qualifiers

Adult Patients who are diagnosed with DM who are willing to participate in the study with informed consent form.

Disqualifiers

Patients with neuritis / neuropathy of the lower extremity due to other causes other than DM

Significant trauma that may cause peripheral nerve damage.

Patient with routine use of corticosteroid

Previous history of smoking

Trial design

Treatments tested in this trial

  • Diagnosis of Charcot foot disease
  • Hematologic and biochemical parameters,
  • ELIZA Assay

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators